| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -41,438 | 100% | $18.41 | -$762,718 |
| Net | -1 | -41,438 | -100% | -$762,718 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher A. Kroeger | Chief Executive Officer, Director | $33,390,444 | 05 Feb 2026 | ||
| Erin Pennock Foff | Chief Medical Officer | $7,701,133 | 05 Feb 2026 | ||
| Vishwas Setia | Chief Financial Officer | $7,543,119 | 05 Feb 2026 | ||
| Robert C. Malenka | Director | $7,016,072 | -$762,718 | -9.8% | 02 Feb 2026 |
| James Woodruff Lillie | Chief Scientific Officer | $5,699,298 | 05 Feb 2026 | ||
| Anatol Kreitzer | Chief Discovery Officer | $4,956,826 | 05 Feb 2026 | ||
| JONATHAN GILLIS | CAAO and PAO | $4,853,753 | 05 Feb 2026 | ||
| Kristopher L. Hanson | General Counsel | $3,653,468 | 05 Feb 2026 | ||
| Timothy John Garnett | Director | 27 Oct 2025 | |||
| Maria C. Walker | Director | 27 Oct 2025 | |||
| Nanna Liebach Luneborg | Director | 25 Oct 2025 | |||
| George Pavlov | Director | 25 Oct 2025 | |||
| James D. Trenkle | Director | 25 Oct 2025 | |||
| Novo Holdings A/S | 10%+ Owner | 28 Oct 2025 | |||
| Catalyst4, Inc. | 10%+ Owner | 28 Oct 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|